trending Market Intelligence /marketintelligence/en/news-insights/trending/KeEL_LWQIjMjN_jRHFgEig2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Intellipharmaceutics to raise $4M

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Intellipharmaceutics to raise $4M

Intellipharmaceutics International Inc. agreed to sell 3,636,364 shares at $1.10 apiece in a registered direct offering with certain investors.

The shares come bundled with warrants to purchase up to an additional 1,818,182 shares at $1.25 apiece.

Intellipharmaceutics expects to raise about $4 million in gross proceeds, which will be used for general corporate purposes.

H.C. Wainwright & Co. is acting as exclusive placement agent for the offering, which is expected to close by Oct. 13.